BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32634463)

  • 1. A panel of circulating long non-coding RNAs as liquid biopsy biomarkers for breast and cervical cancers.
    Barwal TS; Sharma U; Vasquez KM; Prakash H; Jain A
    Biochimie; 2020 Sep; 176():62-70. PubMed ID: 32634463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors.
    Galamb O; Barták BK; Kalmár A; Nagy ZB; Szigeti KA; Tulassay Z; Igaz P; Molnár B
    World J Gastroenterol; 2019 Sep; 25(34):5026-5048. PubMed ID: 31558855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of circulating DSCAM-AS1 in patients with ER-positive breast cancer and construction of its competitive endogenous RNA network.
    Moradi MT; Fallahi H; Rahimi Z
    Mol Biol Rep; 2020 Oct; 47(10):7685-7697. PubMed ID: 33040318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
    El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
    Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional roles of exosomes-derived long non-coding RNA in human cancer.
    Chen F; Wang N; Tan HY; Guo W; Zhang C; Feng Y
    Cancer Biol Ther; 2019; 20(5):583-592. PubMed ID: 30739532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
    Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
    Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy.
    Lasham A; Fitzgerald SJ; Knowlton N; Robb T; Tsai P; Black MA; Williams L; Mehta SY; Harris G; Shelling AN; Blenkiron C; Print CG
    Clin Breast Cancer; 2020 Apr; 20(2):108-116. PubMed ID: 31607655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting Cervical Cancer.
    Sun W; Wang L; Zhao D; Wang P; Li Y; Wang S
    Gynecol Obstet Invest; 2018; 83(6):533-539. PubMed ID: 30134241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNAs as Biomarkers in Cancer.
    Bolha L; Ravnik-Glavač M; Glavač D
    Dis Markers; 2017; 2017():7243968. PubMed ID: 28634418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer?
    Liu J; Wang J; Song Y; Ma B; Luo J; Ni Z; Gao P; Sun J; Zhao J; Chen X; Wang Z
    J Cell Mol Med; 2018 Jul; 22(7):3605-3613. PubMed ID: 29700972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.
    Hosseinalizadeh H; Mahmoodpour M; Ebrahimi A
    Mol Biol Rep; 2022 Jan; 49(1):705-715. PubMed ID: 34677714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
    Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
    Ferracin M; Lupini L; Mangolini A; Negrini M
    Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of circulating biomarkers for differentiating patients with papillary thyroid cancers from benign thyroid tumors.
    Wu SC; Chi SY; Rau CS; Kuo PJ; Huang LH; Wu YC; Wu CJ; Lin HP; Hsieh CH
    J Endocrinol Invest; 2021 Nov; 44(11):2375-2386. PubMed ID: 33646556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating long noncoding RNAs as biomarkers in tumor diagnosis].
    Jiang N; Tian H; Pan J; Gong Z
    Sheng Wu Gong Cheng Xue Bao; 2017 Jun; 33(6):910-922. PubMed ID: 28895353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
    Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Permuth JB; Chen DT; Yoder SJ; Li J; Smith AT; Choi JW; Kim J; Balagurunathan Y; Jiang K; Coppola D; Centeno BA; Klapman J; Hodul P; Karreth FA; Trevino JG; Merchant N; Magliocco A; Malafa MP; Gillies R
    Sci Rep; 2017 Sep; 7(1):10484. PubMed ID: 28874676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
    Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
    Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma long non-coding RNAs (lncRNAs) serve as potential biomarkers for predicting breast cancer.
    Jiao ZY; Tian Q; Li N; Wang HB; Li KZ
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1994-1999. PubMed ID: 29687854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.